Product Information
RASUVO 7.5 MG/0.15 ML AUTOINJ is a brand product labeled by Medexus Pharma Inc., priced at $960.2932 per ML under NDC 59137050504. Its NADAC has been published 67 times since Mar 19, 2025.
The High Outlier badge above means this manufacturer's average price in the methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.5 mg/.15mL
Manufacturer
Medexus Pharma Inc.NDC
59137050504
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
4/1/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA205776On Market Since
7/10/2014
Pharmacological Classes
Price Statistics
The NADAC for RASUVO 7.5 MG/0.15 ML AUTOINJ has been published 67 times since Mar 19, 2025, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $960.2932 per ML |
|---|---|
| All-time high | $960.2932 (Jun 24, 2026) |
| All-time low | $908.7333 (Mar 19, 2025) |
| 52-week high | $960.2932 |
| 52-week low | $936.1226 |
| Median price | $936.1226 |
| Average price | $939.9948 |
| Largest weekly change | +3.0% (Apr 2, 2025) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the methotrexate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RASUVO 7.5 MG/0.15 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for RASUVO 7.5 MG/0.15 ML AUTOINJ, manufactured by Medexus Pharma Inc., is $960.2932 per ML (NDC 59137050504), effective Jun 24, 2026.
How has the price of RASUVO 7.5 MG/0.15 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for RASUVO 7.5 MG/0.15 ML AUTOINJ has risen 5.7%. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for RASUVO 7.5 MG/0.15 ML AUTOINJ?
Since Mar 19, 2025, the NADAC for RASUVO 7.5 MG/0.15 ML AUTOINJ has ranged from a low of $908.7333 (Mar 19, 2025) to a high of $960.2932 (Jun 24, 2026), with a median of $936.1226 per ML.
Are there cheaper alternatives to RASUVO 7.5 MG/0.15 ML AUTOINJ?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RASUVO 7.5 MG/0.15 ML AUTOINJ, so no direct lower-cost alternative is listed.
Who manufactures RASUVO 7.5 MG/0.15 ML AUTOINJ?
RASUVO 7.5 MG/0.15 ML AUTOINJ (NDC 59137050504) is labeled by Medexus Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification